Twitter is said to have had preliminary talks. But Amazon and Snap are also seen to be potential suitors.
Here’s what three potential election outcomes could mean for stocks, industry sectors, and the U.S. economy
Global stocks advanced on Monday, getting a lift from the move by President Donald Trump to unilaterally extend jobless benefits as the coronavirus pandemic continues to weigh on the global economy.
With other tech giants facing antitrust scorn, Microsoft could walk away with a social media gem. Is that a good thing? NYU professor Scott Galloway weighs in.
The business, owned by ByteDance, is a force that cannot be ignored among social-media companies, with its unique blend of content distribution, short-form video, and revenue growth.
NPR reports that the lawsuit will argue that the executive order is unconstitutional because it failed to give the company a chance to respond.
Tech stocks have thrived in 2020 despite mounting geopolitical tension. Why U.S. bans of TikTok and Tencent’s WeChat could be a threat to the Nasdaq’s rally
Apple has rallied 55% this year, adding nearly $700 billion in market value—the equivalent of adding Cisco Systems, Oracle, Salesforce.com, and Zoom Video, with room to spare.
Ambassador Susan Rice, a director at streaming giant Netflix, had set up an automated selling plan that exercised her cheapest options for stock and sold $680,100 worth of them.
The disconnect between the market and the economy continues apace. Could the culprit be negative real interest rates?
The oil behemoth will keep paying dividends—worth about $18 billion a quarter—despite weak energy prices.
The two assets should supplant bonds as inflationary pressures eventually ramp up, argues a Bridgewater Associates’ Bob Prince.
Share buybacks totaled a record $5.1 billion for the quarter.
Risk-off assets, such as gold and Treasuries, also took a breather from their rallies at week’s end. But as the big growth stocks paused, value stocks caught a bid, another positive sign.
An unsolicited rival bid has spurred the private-equity firm to act.
More wild stock trading could be in store for the former photography giant.
Solar panels are selling for stronger-than-expected prices, and First Solar, one of the largest U.S. manufacturers, is optimistic about the future.
Congressman says survey results are “damning.” Investors seem to shrug.
Mulan is coming to Disney+, and how we watch movies might be changing forever. That’s bad news for companies like AMC Entertainment Holdings. Plus, why Apple looks primed for a pullback.
Most of the job gains came from a handful of hard-hit sectors and took the form of part-time jobs. The rest of the economy saw little improvement.
Seniors have been bombarded by pitches to consider option-writing strategies to yield passive retirement income. But there are risks to know before diving in.
Industry leader FirstCash has taken hits from both lockdowns and government aid to individuals.
The drug giant is one of the firms that will manufacture remdesivir, Gilead Sciences’ experimental antiviral that got emergency approval in May as a treatment for Covid-19.
The agreements follow the release of positive results on the biotech’s vaccine.
The Food and Drug Administration has granted priority review status to Biogen’s experimental Alzheimer’s disease drug aducanumab.
